Rolland-Yves Mauvernay
Vorsitzender bei Debiopharm Innovation Fund /Management/
Aktive Positionen von Rolland-Yves Mauvernay
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Debiopharm Innovation Fund /Management/
Debiopharm Innovation Fund /Management/ Investment ManagersFinance Debiopharm Innovation Fund SA develops, manufactures, and markets diagnostic systems. It seeks to invest in the biotechnology, diagnostics, and pharmaceutical industries with a focus on biomarker development, and large molecule capabilities. The firm mission is to invest in innovative diagnostic companies developing platforms and content to complement in-house diagnostic activities, give insight into cutting-edge diagnostics and facilitate access to new technologies. The company was founded in 1979 and is headquartered in Fribourg, Switzerland. | Vorsitzender | - | - |
Karriereverlauf von Rolland-Yves Mauvernay
Ehemalige bekannte Positionen von Rolland-Yves Mauvernay
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Debiopharm International SA
Debiopharm International SA Pharmaceuticals: MajorHealth Technology Debiopharm International SA operates as a biopharmaceutical development company with focus on biologics and drug evaluation, licensing and development. It formulates and develops products for the treatment of cancer, endometriosis, uterine fibroids and hepatitis. The company was founded in 1979 and is headquartered in Lausanne, Switzerland. | Gründer | 01.01.1979 | - |
Präsident | 01.01.1979 | - |
Ausbildung von Rolland-Yves Mauvernay
University of Strasbourg | Doctorate Degree |
Statistik
International
Schweiz | 3 |
Frankreich | 2 |
Operativ
Founder | 1 |
President | 1 |
Doctorate Degree | 1 |
Sektoral
Health Technology | 2 |
Consumer Services | 2 |
Finance | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Debiopharm International SA
Debiopharm International SA Pharmaceuticals: MajorHealth Technology Debiopharm International SA operates as a biopharmaceutical development company with focus on biologics and drug evaluation, licensing and development. It formulates and develops products for the treatment of cancer, endometriosis, uterine fibroids and hepatitis. The company was founded in 1979 and is headquartered in Lausanne, Switzerland. | Health Technology |
Debiopharm Innovation Fund /Management/
Debiopharm Innovation Fund /Management/ Investment ManagersFinance Debiopharm Innovation Fund SA develops, manufactures, and markets diagnostic systems. It seeks to invest in the biotechnology, diagnostics, and pharmaceutical industries with a focus on biomarker development, and large molecule capabilities. The firm mission is to invest in innovative diagnostic companies developing platforms and content to complement in-house diagnostic activities, give insight into cutting-edge diagnostics and facilitate access to new technologies. The company was founded in 1979 and is headquartered in Fribourg, Switzerland. | Finance |
- Börse
- Insiders
- Rolland-Yves Mauvernay
- Erfahrung